Amphastar Pharmaceuticals Inc (AMPH)
48.02
+0.14
(+0.29%)
USD |
NASDAQ |
Sep 27, 16:00
47.98
-0.04
(-0.08%)
After-Hours: 20:00
Amphastar Pharmaceuticals Cash from Financing (Quarterly): -10.72M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -10.72M |
| March 31, 2024 | -13.58M |
| December 31, 2023 | -47.08M |
| September 30, 2023 | 86.61M |
| June 30, 2023 | 428.11M |
| March 31, 2023 | -13.55M |
| December 31, 2022 | -16.16M |
| September 30, 2022 | -13.93M |
| June 30, 2022 | -0.994M |
| March 31, 2022 | 4.648M |
| December 31, 2021 | -8.696M |
| September 30, 2021 | -16.49M |
| June 30, 2021 | -5.191M |
| March 31, 2021 | -6.639M |
| December 31, 2020 | -0.227M |
| September 30, 2020 | -3.026M |
| June 30, 2020 | 12.46M |
| March 31, 2020 | -11.45M |
| December 31, 2019 | -10.38M |
| September 30, 2019 | -3.888M |
| June 30, 2019 | -0.742M |
| March 31, 2019 | 11.23M |
| December 31, 2018 | 16.92M |
| Date | Value |
|---|---|
| September 30, 2018 | 17.80M |
| June 30, 2018 | 1.11M |
| March 31, 2018 | -10.83M |
| December 31, 2017 | -0.802M |
| September 30, 2017 | -5.513M |
| June 30, 2017 | 10.32M |
| March 31, 2017 | -11.72M |
| December 31, 2016 | -1.261M |
| September 30, 2016 | 13.47M |
| June 30, 2016 | 1.962M |
| March 31, 2016 | -7.033M |
| December 31, 2015 | -5.571M |
| September 30, 2015 | -3.721M |
| June 30, 2015 | 7.084M |
| March 31, 2015 | 4.445M |
| December 31, 2014 | -8.553M |
| September 30, 2014 | -1.472M |
| June 30, 2014 | 32.96M |
| March 31, 2014 | 9.18M |
| December 31, 2013 | -3.70M |
| September 30, 2013 | 0.359M |
| June 30, 2013 | -15.57M |
| March 31, 2013 | 9.542M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-47.08M
Minimum
Dec 2023
428.11M
Maximum
Jun 2023
17.49M
Average
-7.668M
Median
Cash from Financing (Quarterly) Benchmarks
| Omeros Corp | -26.88M |
| Harrow Inc | 0.073M |
| PetIQ Inc | 0.063M |
| Amneal Pharmaceuticals Inc | -35.09M |
| Alector Inc | 0.644M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 69.11M |
| Cash from Investing (Quarterly) | -69.90M |
| Free Cash Flow | 178.13M |
| Free Cash Flow Per Share (Quarterly) | 1.212 |
| Free Cash Flow to Equity (Quarterly) | 70.40M |
| Free Cash Flow to Firm (Quarterly) | 67.05M |
| Free Cash Flow Yield | 7.00% |